发明名称 |
DOSAGE FORMS COMPRISING A CETP INHIBITOR AND AN HMG-COA REDUCTASE INHIBITOR |
摘要 |
A dosage form comprises (1) a solid amorphous dispersion comprising a cholesteryl ester transfer protein inhibitor and an acidic concentrationenhancing polymer and (2), an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosag e form.
|
申请公布号 |
CA2509688(A1) |
申请公布日期 |
2004.07.08 |
申请号 |
CA20032509688 |
申请日期 |
2003.12.12 |
申请人 |
PFIZER PRODUCTS INC. |
发明人 |
LYON, DAVID KEITH;LORENZ, DOUGLAS ALAN;MCDERMOTT, TIMOTHY JOSEPH;SHANKER, RAVI MYSORE;HANCOCK, BRUNO CASPAR;FRIESEN, DWAYNE THOMAS |
分类号 |
A61K9/14;A61K9/16;A61K9/20;A61K9/24;A61K31/00;A61K31/40;A61K31/4706;A61K45/06;(IPC1-7):A61K31/40;A61K47/38;A61K31/470 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|